Human TNFRSF4 / OX40 / CD134 Antibody (Vonlerizumab, Research Use)

Product Name	Human TNFRSF4 / OX40 / CD134 Antibody (Vonlerizumab, Research Use)
Catalog Number	NBR-0931
Alias/Synonyms	TXGP1L; ACT35; CD134; OX40
Appearance	Transparent Liquid
Molecule Weight	150kDa
CAS	N/A
Solubility	Water, PBS, TBS Buffer,etc.
Storage	Temp. -80℃
Shelf Life	see COA
Additional info 1	CHO Expressed
Additional info 2	Ab. Isotype - IgG

Catalog Numbe	Size	Price	Inventory Level
NBR-0931-100UG	100ug	$95	Inquire
NBR-0931-1MG	1mg	$650	Inquire
NBR-0931-5MG	5mg	$1395	Inquire

【Introduction】

Product Name: Human TNFRSF4 / OX40 / CD134 Antibody (Vonlerizumab, Research Use)
Catalog Number: NBR-0931
Target Name: TNFRSF4 / OX40 / CD134
Trade Name: Vonlerizumab
Antibody Drug Description: Vonlerolizumab (MOXR 0916) is a humanized IgG agonistic monoclonal OX40-specific antibody. Vonlerolizumab can be used for the research of cancer.

【Description】

Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

【Gene Information】

Gene Name: TNFRSF4
Synonyms: TXGP1L; ACT35; CD134; OX40
Target Description: Receptor for TNFSF4/OX40L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity.
Ensembl: ENSG00000186827
Uniprot: P43489

Top-selling Items